共 155 条
[1]
Dasari A(2017)Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States JAMA Oncol 3 1335-1342
[2]
Shen C(2019)Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013–2015 Br J Cancer 121 966-972
[3]
Halperin D(2016)Italian cancer figures - report 2015. The burden of rare cancers in Italy Epidemiol Prev 40 1-120
[4]
Zhao B(2005)Current status of gastrointestinal carcinoids Gastroenterology 128 1717-1751
[5]
Zhou S(2016)ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site Neuroendocrinology 103 172-185
[6]
Xu Y(2014)Lanreotide in metastatic enteropancreatic neuroendocrine tumors N Engl J Med 371 224-233
[7]
Genus TSE(2009)Placebo-controlled, double-blind, prospective, randomised study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group J Clin Oncol 27 4656-4663
[8]
Bouvier C(2016)Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study Lancet 387 968-977
[9]
Wong KF(2011)Everolimus for advanced pancreatic neuroendocrine tumors N Engl J Med 364 514-523
[10]
Srirajaskanthan R(2011)Sunitinib malate for the treatment of pancreatic neuroendocrine tumors N Engl J Med 364 501-513